Spark Therapeutics Iħabbar Data Aġġornata dwar SPK-8011 mill-Fażi 1/2 Prova Klinika fl-Emofilja A fil-Kungress Virtwali ISTH 2020

Spark Therapeutics Iħabbar Data Aġġornata dwar SPK-8011 mill-Fażi 1/2 Prova Klinika fl-Emofilja A fil-Kungress Virtwali ISTH 2020

Terapewtika Spark

Image

Please enable the javascript to submit this form

Appoġġjati minn għotjiet edukattivi minn Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, u uniQure, Inc.

SSL essenzjali